These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
603 related articles for article (PubMed ID: 28733960)
21. The dynamics of plasma biomarkers across the Alzheimer's continuum. Guo Y; Shen XN; Wang HF; Chen SD; Zhang YR; Chen SF; Cui M; Cheng W; Dong Q; Ma T; Yu JT Alzheimers Res Ther; 2023 Feb; 15(1):31. PubMed ID: 36750875 [TBL] [Abstract][Full Text] [Related]
23. A Non-APOE Polygenic Risk Score for Alzheimer's Disease Is Associated With Cerebrospinal Fluid Neurofilament Light in a Representative Sample of Cognitively Unimpaired 70-Year Olds. Skoog I; Kern S; Najar J; Guerreiro R; Bras J; Waern M; Zetterberg H; Blennow K; Zettergren A J Gerontol A Biol Sci Med Sci; 2021 May; 76(6):983-990. PubMed ID: 33512503 [TBL] [Abstract][Full Text] [Related]
24. Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia. Giuffrè GM; Quaranta D; Costantini EM; Citro S; Martellacci N; De Ninno G; Vita MG; Guglielmi V; Rossini PM; Calabresi P; Marra C Neurobiol Dis; 2023 Oct; 186():106267. PubMed ID: 37652185 [TBL] [Abstract][Full Text] [Related]
25. Microglial Activation, Tau Pathology, and Neurodegeneration Biomarkers Predict Longitudinal Cognitive Decline in Alzheimer's Disease Continuum. Chen YH; Lin RR; Huang HF; Xue YY; Tao QQ Front Aging Neurosci; 2022; 14():848180. PubMed ID: 35847667 [TBL] [Abstract][Full Text] [Related]
26. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Fortea J; Carmona-Iragui M; Benejam B; Fernández S; Videla L; Barroeta I; Alcolea D; Pegueroles J; Muñoz L; Belbin O; de Leon MJ; Maceski AM; Hirtz C; Clarimón J; Videla S; Delaby C; Lehmann S; Blesa R; Lleó A Lancet Neurol; 2018 Oct; 17(10):860-869. PubMed ID: 30172624 [TBL] [Abstract][Full Text] [Related]
27. Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults. Sprecher KE; Koscik RL; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Sager MA; Asthana S; Johnson SC; Benca RM; Bendlin BB Neurology; 2017 Aug; 89(5):445-453. PubMed ID: 28679595 [TBL] [Abstract][Full Text] [Related]
28. Associations of longitudinal plasma p-tau181 and NfL with tau-PET, Aβ-PET and cognition. Rauchmann BS; Schneider-Axmann T; Perneczky R; J Neurol Neurosurg Psychiatry; 2021 Dec; 92(12):1289-1295. PubMed ID: 34187867 [TBL] [Abstract][Full Text] [Related]
32. Plasma neuregulin 1 as a synaptic biomarker in Alzheimer's disease: a discovery cohort study. Vrillon A; Mouton-Liger F; Martinet M; Cognat E; Hourregue C; Dumurgier J; Bouaziz-Amar E; Brinkmalm A; Blennow K; Zetterberg H; Hugon J; Paquet C Alzheimers Res Ther; 2022 May; 14(1):71. PubMed ID: 35606871 [TBL] [Abstract][Full Text] [Related]
33. Plasma β-amyloid, tau, neurodegeneration biomarkers and inflammatory factors of probable Alzheimer's disease dementia in Chinese individuals. Sun Q; Ni J; Wei M; Long S; Li T; Fan D; Lu T; Shi J; Tian J Front Aging Neurosci; 2022; 14():963845. PubMed ID: 36062146 [TBL] [Abstract][Full Text] [Related]
34. Synaptic biomarkers in the cerebrospinal fluid associate differentially with classical neuronal biomarkers in patients with Alzheimer's disease and frontotemporal dementia. Das S; Goossens J; Jacobs D; Dewit N; Pijnenburg YAL; In 't Veld SGJG; Teunissen CE; Vanmechelen E Alzheimers Res Ther; 2023 Mar; 15(1):62. PubMed ID: 36964594 [TBL] [Abstract][Full Text] [Related]
35. Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease. Grau-Rivera O; Navalpotro-Gomez I; Sánchez-Benavides G; Suárez-Calvet M; Milà-Alomà M; Arenaza-Urquijo EM; Salvadó G; Sala-Vila A; Shekari M; González-de-Echávarri JM; Minguillón C; Niñerola-Baizán A; Perissinotti A; Simon M; Kollmorgen G; Zetterberg H; Blennow K; Gispert JD; Molinuevo JL; Alzheimers Res Ther; 2021 Feb; 13(1):46. PubMed ID: 33597012 [TBL] [Abstract][Full Text] [Related]
36. Performance of Plasma Amyloid β, Total Tau, and Neurofilament Light Chain in the Identification of Probable Alzheimer's Disease in South China. Jiao B; Liu H; Guo L; Liao X; Zhou Y; Weng L; Xiao X; Zhou L; Wang X; Jiang Y; Yang Q; Zhu Y; Zhou L; Zhang W; Wang J; Yan X; Tang B; Shen L Front Aging Neurosci; 2021; 13():749649. PubMed ID: 34776933 [No Abstract] [Full Text] [Related]
37. Saliva Neurofilament Light Chain Is Not a Diagnostic Biomarker for Neurodegeneration in a Mixed Memory Clinic Population. Gleerup HS; Sanna F; Høgh P; Simrén J; Blennow K; Zetterberg H; Hasselbalch SG; Ashton NJ; Simonsen AH Front Aging Neurosci; 2021; 13():659898. PubMed ID: 34040512 [TBL] [Abstract][Full Text] [Related]
38. Addition of the Aβ42/40 ratio to the cerebrospinal fluid biomarker profile increases the predictive value for underlying Alzheimer's disease dementia in mild cognitive impairment. Baldeiras I; Santana I; Leitão MJ; Gens H; Pascoal R; Tábuas-Pereira M; Beato-Coelho J; Duro D; Almeida MR; Oliveira CR Alzheimers Res Ther; 2018 Mar; 10(1):33. PubMed ID: 29558986 [TBL] [Abstract][Full Text] [Related]